BETHESDA, Md. (MedPage Today) -- A joint FDA advisory committee will meet here Friday to consider whether the narcolepsy drug sodium oxybate (Xyrem) should receive an additional indication to treat fibromyalgia...

FDA Panel Looks at CNS Depressant for Fibromyalgia (click here for the full article at MedPage Today)